• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The impact of extracorporeal membrane oxygenation on the exposure to isavuconazole: a plea for thorough pharmacokinetic evaluation.

作者信息

Mertens Beatrijs, Wauters Joost, Debaveye Yves, Van Regenmortel Niels, Degezelle Karlien, Meersseman Philippe, Hermans Greet, Vandenbriele Christophe, Van Daele Ruth, Spriet Isabel

机构信息

Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.

Pharmacy Department, University Hospitals Leuven, Leuven, Belgium.

出版信息

Crit Care. 2022 Jul 27;26(1):227. doi: 10.1186/s13054-022-04093-y.

DOI:10.1186/s13054-022-04093-y
PMID:35897020
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9325953/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/451f/9327370/46609b5f3917/13054_2022_4093_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/451f/9327370/46609b5f3917/13054_2022_4093_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/451f/9327370/46609b5f3917/13054_2022_4093_Fig1_HTML.jpg

相似文献

1
The impact of extracorporeal membrane oxygenation on the exposure to isavuconazole: a plea for thorough pharmacokinetic evaluation.体外膜肺氧合对艾沙康唑暴露量的影响：呼吁进行全面的药代动力学评估。
Crit Care. 2022 Jul 27;26(1):227. doi: 10.1186/s13054-022-04093-y.
2
[Pharmacokinetic monitoring of isavuconazole in a patient with extracorporeal membrane oxygenation support].[体外膜肺氧合支持患者中艾沙康唑的药代动力学监测]
Rev Esp Quimioter. 2024 Apr;37(2):183-185. doi: 10.37201/req/120.2023. Epub 2024 Feb 9.
3
Decreased isavuconazole trough concentrations in the treatment of invasive aspergillosis in an adult patient receiving extracorporeal membrane oxygenation support.在接受体外膜氧合支持的成年患者中，治疗侵袭性曲霉菌病时伊曲康唑的谷浓度降低。
Am J Health Syst Pharm. 2022 Jul 22;79(15):1245-1249. doi: 10.1093/ajhp/zxac043.
4
Isavuconazole plasma concentrations in critically ill patients during extracorporeal membrane oxygenation.体外膜肺氧合患者中重症患者的伊曲康唑血浆浓度。
J Antimicrob Chemother. 2022 Aug 25;77(9):2500-2505. doi: 10.1093/jac/dkac196.
5
Comment on: Isavuconazole plasma concentrations in critically ill patients during extracorporeal membrane oxygenation.关于《体外膜肺氧合期间危重症患者的艾沙康唑血药浓度》的评论
J Antimicrob Chemother. 2022 Nov 28;77(12):3526-3527. doi: 10.1093/jac/dkac316.
6
Isavuconazole plasma concentrations in critically ill patients during extracorporeal membrane oxygenation-authors' response.体外膜肺氧合期间危重症患者的艾沙康唑血药浓度——作者回复
J Antimicrob Chemother. 2022 Nov 28;77(12):3528-3529. doi: 10.1093/jac/dkac357.
7
Isavuconazole: A new broad-spectrum azole. Part 2: pharmacokinetics and clinical activity.伊曲康唑：一种新型广谱唑类药物。第 2 部分：药代动力学和临床活性。
J Mycol Med. 2018 Mar;28(1):15-22. doi: 10.1016/j.mycmed.2018.02.002. Epub 2018 Mar 16.
8
Isavuconazonium sulfate: a triazole prodrug for invasive fungal infections.硫酸艾沙康唑：一种用于侵袭性真菌感染的三唑前体药物。
Int J Pharm Pract. 2017 Feb;25(1):18-30. doi: 10.1111/ijpp.12302. Epub 2016 Aug 29.
9
The pharmacokinetic challenge of treating invasive aspergillosis complicating severe influenzae assisted by extracorporeal membrane oxygenation.体外膜肺氧合辅助治疗并发严重流感的侵袭性曲霉病的药代动力学挑战。
Crit Care. 2018 Dec 22;22(1):355. doi: 10.1186/s13054-018-2285-5.
10
A Review of the Clinical Pharmacokinetics and Pharmacodynamics of Isavuconazole.艾沙康唑的临床药代动力学与药效学综述
Eur J Drug Metab Pharmacokinet. 2018 Jun;43(3):281-290. doi: 10.1007/s13318-017-0445-7.

引用本文的文献

1
Low isavuconazole trough levels in critically ill patients with and without extracorporeal membrane oxygenation.伴有和不伴有体外膜肺氧合的危重症患者中艾沙康唑谷浓度较低。
Antimicrob Agents Chemother. 2025 Sep 3;69(9):e0057725. doi: 10.1128/aac.00577-25. Epub 2025 Jul 23.
2
Teicoplanin pharmacokinetics in critically ill patients on extracorporeal organ support: a retrospective analysis.体外器官支持下重症患者的替考拉宁药代动力学：一项回顾性分析。
Intensive Care Med Exp. 2025 Feb 21;13(1):22. doi: 10.1186/s40635-025-00729-9.
3
A narrative review on antimicrobial dosing in adult critically ill patients on extracorporeal membrane oxygenation.

本文引用的文献

1
Decreased isavuconazole trough concentrations in the treatment of invasive aspergillosis in an adult patient receiving extracorporeal membrane oxygenation support.在接受体外膜氧合支持的成年患者中，治疗侵袭性曲霉菌病时伊曲康唑的谷浓度降低。
Am J Health Syst Pharm. 2022 Jul 22;79(15):1245-1249. doi: 10.1093/ajhp/zxac043.
2
A Large Retrospective Assessment of Voriconazole Exposure in Patients Treated with Extracorporeal Membrane Oxygenation.接受体外膜肺氧合治疗患者伏立康唑暴露情况的大型回顾性评估
Microorganisms. 2021 Jul 20;9(7):1543. doi: 10.3390/microorganisms9071543.
3
Pharmacokinetics and target attainment of intravenous posaconazole in critically ill patients during extracorporeal membrane oxygenation.
体外膜肺氧合成人危重症患者的抗菌药物剂量：叙述性综述
Crit Care. 2024 Oct 4;28(1):326. doi: 10.1186/s13054-024-05101-z.
4
[Pharmacokinetic monitoring of isavuconazole in a patient with extracorporeal membrane oxygenation support].[体外膜肺氧合支持患者中艾沙康唑的药代动力学监测]
Rev Esp Quimioter. 2024 Apr;37(2):183-185. doi: 10.37201/req/120.2023. Epub 2024 Feb 9.
5
Isavuconazole Exposure in Critically Ill Patients Treated with Extracorporeal Membrane Oxygenation: Two Case Reports and a Narrative Literature Review.接受体外膜肺氧合治疗的重症患者的艾沙康唑暴露情况：两例病例报告及文献综述
Antibiotics (Basel). 2023 Jun 21;12(7):1085. doi: 10.3390/antibiotics12071085.
6
Antifungal Dosing in Critically Ill Patients on Extracorporeal Membrane Oxygenation.体外膜肺氧合患者的抗真菌药物剂量。
Clin Pharmacokinet. 2023 Jul;62(7):931-942. doi: 10.1007/s40262-023-01264-0. Epub 2023 Jun 10.
体外膜肺氧合患者中静脉注射泊沙康唑的药代动力学和靶目标达成情况。
J Antimicrob Chemother. 2021 Apr 13;76(5):1234-1241. doi: 10.1093/jac/dkab012.
4
Isavuconazole Treatment in a Mixed Patient Cohort with Invasive Fungal Infections: Outcome, Tolerability and Clinical Implications of Isavuconazole Plasma Concentrations.在患有侵袭性真菌感染的混合患者队列中使用艾沙康唑治疗：艾沙康唑血药浓度的疗效、耐受性及临床意义
J Fungi (Basel). 2020 Jun 22;6(2):90. doi: 10.3390/jof6020090.
5
Altered Pharmacokinetics and Dosing of Liposomal Amphotericin B and Isavuconazole during Extracorporeal Membrane Oxygenation.在体外膜肺氧合期间，脂质体两性霉素 B 和伊曲康唑的药代动力学和剂量发生改变。
Pharmacotherapy. 2020 Jan;40(1):89-95. doi: 10.1002/phar.2348. Epub 2019 Dec 13.